The failure rate for those already entered Phase 1 trials to be successfully approval, is around 90%, also it usually takes 10 to 15 years to final FDA approval stage.
Reata, took 21 years to successfully develop Skyclarys to obtain FDA APPROVAL.
Coincidentally, NEU’s DAYBUE, also is taken 21 years from the scratch to FDA APPROVAL.
To develop a drug, is a marathon exercise with very low success rate, imo.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.02 |
Change
0.710(5.33%) |
Mkt cap ! $1.745B | |||
| Open | High | Low | Value | Volume |
| $13.50 | $14.09 | $12.96 | $5.201M | 379.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2 | $14.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.03 | 103 | 5 |
View Market Depth
| Last trade - 13.12pm 27/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |